• Leveljump Healthcare has acquired an additional percentage of Real Time Medical
  • The telehealth solutions company has acquired an additional 8.3-percent stake in Real Time Medical, a private Ontario company
  • The all-stock deal is worth approximately $924-thousand
  • The deal means Leveljump now owns a 25.21-percent interest in Real Time Medical
  • Leveljump Healthcare is unchanged, trading at $0.095 at 1:11 p.m. EST

Leveljump Healthcare (JUMP) has acquired an additional percentage of Real Time Medical.

The Toronto-based telehealth solutions company has acquired an additional 8.3-percent stake in Real Time Medical, a private Ontario company.

The all-stock deal is worth approximately $924-thousand.

The deal means Leveljump now owns a 25.21-percent interest in Real Time Medical.

The transaction has been approved by the TSX Venture Exchange.

In addition, Leveljump has agreed to purchase a promissory note, due from Real Time Medical to a vendor, with a face amount of $100,000 and accrued interest of approximately $30,000.

Leveljump continues to focus on profitable telehealth solutions as well as primary care services in radiology. T

The company’s subsidiary, CTS, provides off-site radiology readings for hospital emergency rooms and is a leader in the teleradiology space in Ontario.

Leveljump Healthcare is unchanged, trading at $0.095 at 1:11 p.m. EST.

More From The Market Online

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.